Piramal Pharma Announces $90 Mn Expansion for Two US Manufacturing Sites

The Mumbai-based firm stated that the expansion aligns with growing demand from US clients and the broader shift toward domestic drug supply chains.

Piramal Pharma Limited has announced a $90 million investment to expand its manufacturing sites in Lexington, Kentucky, and Riverview, Michigan. The Mumbai-based firm stated that the expansion aligns with growing demand from US clients and the broader shift toward domestic drug supply chains.

The investment, disclosed at the 2025 SelectUSA Investment Summit, will be funded through internal accruals and bank loans. The company emphasized that these brownfield expansions represent the fastest and most cost-efficient approach to enhancing capacity in the US market.

The Lexington facility, which specializes in sterile injectable drug products, is adding 24,000 square feet of manufacturing space and a new laboratory. This expansion will support commercial-scale production, including a new filling line, two large-scale lyophilisers, an external vial washer, and a capping machine. The site is expected to be operational by late 2027.

The Riverview facility—known for its work with APIs and high potency APIs—is set to add a commercial-scale suite focused on payload-linker development. These components are critical to manufacturing antibody-drug conjugates (ADCs) and other bioconjugate drugs. The new suite is scheduled to go online before the end of 2025.

Peter DeYoung, CEO, Global Pharma, said, "Since its inception, Piramal Pharma Ltd has invested $570 million in its US drug development and manufacturing capabilities. The US is our largest market, employing approximately 750 people. Expanding the capacities and offerings in these two plants in the US, along with the prior major investments made in our Sellersville PA, drug product facility, and our inhalation anesthesia drug substance and drug product facility in Bethlehem PA, will support our customers who value our offerings in an onshore setting."